With IV drug use accounting for 60% of new infections, treatment for individuals in this population is necessary to stave off new infections.
Amanda Binkley, PharmD, AAHIVP
Advertisement
Articles by Amanda Binkley, PharmD, AAHIVP
What can healthcare providers do to stop these infections before they start?
Advertisement
Latest Updated Articles
- Epclusa: What Have We Learned?
January 1st 2017
- Preventing Clostridium difficile From Getting Loose
May 10th 2017
Advertisement
Advertisement
Trending on Contagion Live
1
Lenacapavir and the Future of HIV Prevention: PURPOSE Trials, Long-Acting PrEP, and What Comes Next
2
Initiatives Look to Strengthen Vaccine Policy and Governance in US
3
Hackensack Meridian Health Joins Phase 3 Trial of Pfizer’s Investigational C difficile Vaccine
4
Infectious Disease Regulatory Watch: June Highlights
5